A Research Study to Compare a New Weekly Insulin, Insulin Icodec, and an Available Daily Insulin, Insulin Degludec, Both in Combination With Mealtime Insulin in People With Type 1 Diabetes (ONWARDS 6)

Clinical trial NCT04848480 · COMPLETED

Trial details

NCT number: NCT04848480
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 1

Start date: 2021-04-30
Primary completion: 2022-04-28
Enrollment: 582

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.